{"id":935580,"date":"2026-02-10T09:53:11","date_gmt":"2026-02-10T14:53:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/"},"modified":"2026-02-10T09:53:11","modified_gmt":"2026-02-10T14:53:11","slug":"fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/","title":{"rendered":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University"},"content":{"rendered":"
\n

HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Chairman and CEO Pete O\u2019Heeron<\/strong> has been invited to serve as a main stage<\/strong>speaker<\/strong> at the upcoming A4LI\u2019s<\/strong>H-SPAN Summit at Georgetown University.<\/strong><\/p>\n

The summit, taking place June 29\u2013July 1, 2026,<\/strong> is hosted by the Alliance for Longevity Initiatives (A4LI) <\/strong>and is recognized as a premier event bringing together leaders, innovators, policymakers, and advocates from across the globe to advance legislative and scientific initiatives aimed at promoting healthier human lifespans. The three-day event will be held on the Georgetown University Capitol Campus<\/strong> and will culminate in a Congressional Briefing and Hill Day<\/strong> on Capitol Hill.<\/p>\n

\u201cWe are proud to have Pete represent FibroBiologics on the H-SPAN stage,\u201d said Dylan Livingston, Founder\/CEO of Alliance For Longevity Initiatives. \u201cThymic regenerative biology is a potentially transformative area of research for extending healthy human lifespan, and Pete is a trailblazer in this space. FibroBiologics\u2019 commitment to addressing chronic diseases aligns directly with the goals of the summit and A4LI\u2019s mission of accelerating innovation that extends human healthspan.\u201d<\/p>\n

At the summit, Mr. O\u2019Heeron will address an expert audience of researchers, biotech executives, and policy leaders on the next frontier of longevity science, including breakthroughs in cellular therapeutics and strategies for translating research into real-world clinical impact.<\/p>\n

The Summit unites scientific advancement with policy frameworks, with Day 1 focusing on cutting-edge longevity research, Day 2 on frameworks for innovation policy, and Day 3 on direct advocacy with members of Congress to elevate national healthspan priorities. This year\u2019s agenda reflects growing momentum in the biotech longevity ecosystem and underscores the importance of cross-sector collaboration.<\/p>\n

\u201cI\u2019m honored to be selected as one of the main stage speakers for the H-SPAN Summit and to contribute to this important national dialogue,\u201d said Pete O\u2019Heeron. \u201cFibroBiologics is committed to advancing therapies that prevent and treat chronic disease along with extending human life, and summits like this are essential for aligning scientific innovation with policy action.\u201d<\/p>\n

The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) organization advancing legislation and policies that aim to increase healthy human lifespan and accelerate equitable access to next-generation therapies. The H-SPAN Summit has quickly become a leading forum for shaping America\u2019s longevity policy agenda.<\/p>\n

\n About FibroBiologics<\/strong>\n <\/p>\n

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents\/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit www.FibroBiologics.com<\/u><\/a>.<\/p>\n

\n General Inquiries:<\/strong>
\n
\n
\n info@fibrobiologics.com<\/u>
\n <\/a>\n <\/p>\n

\n Investor Relations:<\/strong>
\n
Nic Johnson
Russo Partners
(212) 845-4242
fibrobiologicsIR@russopr.com<\/u><\/a><\/p>\n

\n Media Contact:
<\/strong>Liz Phillips\u00a0
Russo Partners\u00a0
(347) 956-7697\u00a0
Elizabeth.phillips@russopartnersllc.com<\/a><\/p>\n

For more information on A4LI\u2019s H-SPAN Summit at Georgetown University or to register, visit:\u00a0https:\/\/a4li.org\/h-span-summit-dc\/<\/u><\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Chairman and CEO Pete O\u2019Heeron has been invited to serve as a main stagespeaker at the upcoming A4LI\u2019sH-SPAN Summit at Georgetown University. The summit, taking place June 29\u2013July 1, 2026, is hosted by the Alliance for Longevity Initiatives (A4LI) and is recognized as a premier event bringing together leaders, innovators, policymakers, and advocates from across the globe to advance legislative and scientific initiatives aimed at promoting healthier human lifespans. The three-day event will … <\/p>\n

Continue reading “FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-935580","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Chairman and CEO Pete O\u2019Heeron has been invited to serve as a main stagespeaker at the upcoming A4LI\u2019sH-SPAN Summit at Georgetown University. The summit, taking place June 29\u2013July 1, 2026, is hosted by the Alliance for Longevity Initiatives (A4LI) and is recognized as a premier event bringing together leaders, innovators, policymakers, and advocates from across the globe to advance legislative and scientific initiatives aimed at promoting healthier human lifespans. The three-day event will … Continue reading "FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T14:53:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University\",\"datePublished\":\"2026-02-10T14:53:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/\"},\"wordCount\":551,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/\",\"name\":\"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=\",\"datePublished\":\"2026-02-10T14:53:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/","og_locale":"en_US","og_type":"article","og_title":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk","og_description":"HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (\u201cFibroBiologics\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Chairman and CEO Pete O\u2019Heeron has been invited to serve as a main stagespeaker at the upcoming A4LI\u2019sH-SPAN Summit at Georgetown University. The summit, taking place June 29\u2013July 1, 2026, is hosted by the Alliance for Longevity Initiatives (A4LI) and is recognized as a premier event bringing together leaders, innovators, policymakers, and advocates from across the globe to advance legislative and scientific initiatives aimed at promoting healthier human lifespans. The three-day event will … Continue reading \"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-10T14:53:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University","datePublished":"2026-02-10T14:53:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/"},"wordCount":551,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/","name":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=","datePublished":"2026-02-10T14:53:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTk1OSM3NDE3NDg1IzIyNjM1MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fibrobiologics-chairman-ceo-pete-oheeron-selected-to-present-at-a4lis-h-span-summit-at-georgetown-university\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FibroBiologics\u2019 Chairman & CEO Pete O\u2019Heeron Selected to Present at A4LI\u2019s H-SPAN Summit at Georgetown University"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=935580"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935580\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=935580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=935580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=935580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}